Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster influenza vaccination in quiescent systemic lupus erythematosus
2007-004579-21Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of influenza vaccine, inactivated, surface antigen in systemic lupus erythematosus (SLE) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Seroprotection rate. Started Aug 2007; status: active.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2007-004579-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004579-21.